Juan-Carlos Jiménez-Castellanos1, Wan Nur Ismah Wan Ahmad Kamil2, Ching Hei Phoebe Cheung1, Maryann S Tobin1, James Brown1, Sophie G Isaac1, Kate J Heesom3, Thamarai Schneiders4, Matthew B Avison5. 1. School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK. 2. School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK Faculty of Biotechnology & Biomolecular Sciences, Universiti Putra Malaysia, Selangor Darul Ehsan, Malaysia. 3. Bristol University Proteomics Facility, University of Bristol, Bristol, UK. 4. Division of Infection and Pathway Medicine, University of Edinburgh, Edinburgh, UK. 5. School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK matthewb.avison@bristol.ac.uk.
Abstract
OBJECTIVES: In Klebsiella pneumoniae, overproduction of RamA and RarA leads to increased MICs of various antibiotics; MarA and SoxS are predicted to perform a similar function. We have compared the relative effects of overproducing these four AraC-type regulators on envelope permeability (a combination of outer membrane permeability and efflux), efflux pump and porin production, and antibiotic susceptibility in K. pneumoniae. METHODS: Regulators were overproduced using a pBAD expression vector. Antibiotic susceptibility was measured using disc testing. Envelope permeability was estimated using a fluorescent dye accumulation assay. Porin and efflux pump production was quantified using proteomics and validated using real-time quantitative RT-PCR. RESULTS: Envelope permeability and antibiotic disc inhibition zone diameters both reduced during overproduction of RamA and to a lesser extent RarA or SoxS, but did not change following overproduction of MarA. These effects were associated with overproduction of the efflux pumps AcrAB (for RamA and SoxS) and OqxAB (for RamA and RarA) and the outer membrane protein TolC (for all regulators). Effects on porin production were strain specific. CONCLUSIONS: RamA is the most potent regulator of antibiotic permeability in K. pneumoniae, followed by RarA then SoxS, with MarA having very little effect. This observed relative potency correlates well with the frequency at which these regulators are reportedly overproduced in clinical isolates.
OBJECTIVES: In Klebsiella pneumoniae, overproduction of RamA and RarA leads to increased MICs of various antibiotics; MarA and SoxS are predicted to perform a similar function. We have compared the relative effects of overproducing these four AraC-type regulators on envelope permeability (a combination of outer membrane permeability and efflux), efflux pump and porin production, and antibiotic susceptibility in K. pneumoniae. METHODS: Regulators were overproduced using a pBAD expression vector. Antibiotic susceptibility was measured using disc testing. Envelope permeability was estimated using a fluorescent dye accumulation assay. Porin and efflux pump production was quantified using proteomics and validated using real-time quantitative RT-PCR. RESULTS: Envelope permeability and antibiotic disc inhibition zone diameters both reduced during overproduction of RamA and to a lesser extent RarA or SoxS, but did not change following overproduction of MarA. These effects were associated with overproduction of the efflux pumps AcrAB (for RamA and SoxS) and OqxAB (for RamA and RarA) and the outer membrane protein TolC (for all regulators). Effects on porin production were strain specific. CONCLUSIONS: RamA is the most potent regulator of antibiotic permeability in K. pneumoniae, followed by RarA then SoxS, with MarA having very little effect. This observed relative potency correlates well with the frequency at which these regulators are reportedly overproduced in clinical isolates.
Authors: Charles R Dean; David T Barkan; Alun Bermingham; Johanne Blais; Fergal Casey; Anthony Casarez; Richard Colvin; John Fuller; Adriana K Jones; Cindy Li; Sara Lopez; Louis E Metzger; Mina Mostafavi; Ramadevi Prathapam; Dita Rasper; Folkert Reck; Alexey Ruzin; Jacob Shaul; Xiaoyu Shen; Robert L Simmons; Peter Skewes-Cox; Kenneth T Takeoka; Pramila Tamrakar; Tsuyoshi Uehara; Jun-Rong Wei Journal: Antimicrob Agents Chemother Date: 2018-09-24 Impact factor: 5.191
Authors: Wan Ahmad Kamil Wan Nur Ismah; Yuiko Takebayashi; Jacqueline Findlay; Kate J Heesom; Juan-Carlos Jiménez-Castellanos; Jay Zhang; Lee Graham; Karen Bowker; O Martin Williams; Alasdair P MacGowan; Matthew B Avison Journal: Antimicrob Agents Chemother Date: 2018-02-23 Impact factor: 5.191
Authors: Ching Hei Phoebe Cheung; Mohammed Alorabi; Fergus Hamilton; Yuiko Takebayashi; Oliver Mounsey; Kate J Heesom; Philip B Williams; O Martin Williams; Mahableshwar Albur; Alasdair P MacGowan; Matthew B Avison Journal: Antimicrob Agents Chemother Date: 2021-07-16 Impact factor: 5.191
Authors: Jürgen Brem; Ricky Cain; Samuel Cahill; Michael A McDonough; Ian J Clifton; Juan-Carlos Jiménez-Castellanos; Matthew B Avison; James Spencer; Colin W G Fishwick; Christopher J Schofield Journal: Nat Commun Date: 2016-08-08 Impact factor: 14.919
Authors: Michelle M C Buckner; Howard T H Saw; Rachael N Osagie; Alan McNally; Vito Ricci; Matthew E Wand; Neil Woodford; Alasdair Ivens; Mark A Webber; Laura J V Piddock Journal: mBio Date: 2018-04-24 Impact factor: 7.867